ACXPAcurx Pharmaceuticals, Inc.May 12, 2026Q1 2026
Read transcript →Acurx Pharmaceuticals, Inc. (ACXP) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$1.39
-1.42%
Mkt Cap $3.10M
ACXPAcurx Pharmaceuticals, Inc.May 12, 2026ACXPAcurx Pharmaceuticals, Inc.Nov 12, 2025Q3 2025
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Aug 12, 2025Q2 2025
Read transcript →ACXPAcurx Pharmaceuticals, Inc.May 13, 2025Q1 2025
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Mar 18, 2025Q4 2024
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Nov 13, 2024Q3 2024
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Aug 9, 2024Q2 2024
Read transcript →ACXPAcurx Pharmaceuticals, Inc.May 15, 2024Q1 2024
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Mar 18, 2024Q4 2023
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Nov 14, 2023Q3 2023
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Aug 14, 2023Q2 2023
Read transcript →ACXPAcurx Pharmaceuticals, Inc.May 12, 2023Q1 2023
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Mar 16, 2023Q4 2022
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Nov 14, 2022Q3 2022
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Aug 16, 2022Q2 2022
Read transcript →ACXPAcurx Pharmaceuticals, Inc.May 11, 2022Q1 2022
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Mar 17, 2022Q4 2021
Read transcript →ACXPAcurx Pharmaceuticals, Inc.Nov 15, 2021Q3 2021
Read transcript →